Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug results
Shares of Denmark's Zealand Pharma rocketed higher, after the company posted strong results from a trial of a liver disease treatment that has been touted as a potential competitor in the booming weight loss drug market.